225 results on '"Mullane, Michael"'
Search Results
2. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
3. Land of the rising gold
4. Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
5. Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial
6. Disparities in outcomes of pancreatic cancer hospitalizations: A ten-year trend study.
7. Impact of pneumocystis pneumonia on clinical outcomes in patients with lung malignancy compared to other malignancies.
8. Acute cardiac complications in colorectal cancer compared to other gastrointestinal malignancies: A 10-year retrospective study.
9. Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib
10. Trends and disparities in palliative care utilization among patients with anal cancer: A ten-year retrospective study.
11. Tolerability and long-term disease control by IGHV mutation status among patients with CLL on ibrutinib arm of E1912
12. Effects of word overlap on generalized gains from a repeated readings intervention
13. Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3
14. Trends and disparities in colorectal cancer hospitalizations and outcomes: a 10-year joinpoint trend study.
15. The Pallof Press
16. Efficacy of Upfront Docetaxel With Androgen Deprivation Therapy for Castration-Sensitive Metastatic Prostate Cancer Among Minority Patients
17. Gastric Cancer in a Patient with Laparoscopic Adjustable Gastric Band: Case Report and Review of Literature
18. A Comprehensive Cancer Risk Management Clinic for Families With Hereditary Cancer Syndromes: Outcomes After 6 Years
19. Exercise Technique: The Dead Bug
20. Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).
21. Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing
22. Retrospective Analysis of Factors Associated With Venous Thromboembolism Among Pancreatic Cancer Patients: A Single Institution Experience
23. Strength and Conditioning Considerations for Hurling: An Amateur Gaelic Games Sport
24. Quantifying the Value of the Molecular Tumor Board: Discordance Recommendation Rate and Drug Cost Avoidance
25. Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZV HT ) in Immunocompromised Adults
26. Metastatic spread from squamous cell carcinoma of the hypopharynx to the totally implantable venous access port insertion site: Case report and review of literature
27. Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies
28. Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing (3V): Real-world data from large midwestern healthcare system.
29. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
30. Characteristics of Patients with Hematologic Malignancies Without Seroconversion Post-COVID19 Third Vaccine Dosing
31. Needle Tract Seeding Following Irreversible Electroporation (IRE) of Metastatic Colorectal Carcinoma to the Liver
32. Abstract P3-14-17: Exploring racial disparities in BRCA testing for triple negative breast cancer patients: A real-world data analysis
33. Numerical Experiments of Counterflowiing Jet Effects on Supersonic Slender-Body Configurations
34. Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types.
35. Healthcare utilization and outcomes in HIV versus non-HIV patients with anal cancer: A nationwide analysis.
36. A nationwide analysis of inpatient outcomes and healthcare utilization in HIV versus non-HIV patients with esophageal cancer.
37. Healthcare utilization and outcomes in HIV versus non-HIV patients with hepatocellular cancer: A nationwide analysis.
38. A nationwide analysis of outcomes and healthcare utilization in HIV versus non-HIV patients with colon cancer.
39. Statutory interpretation in Arkansas: how Arkansas courts interpret statutes, a rational approach.
40. Statutory interpretation in Arkansas: how should a statute be read? When is it subject to interpretation? What our courts say and what they do.
41. Preference for variable over fixed delays to reinforcement: A demonstration of risk sensitivity during functional communication training.
42. Contingent Electric Shock as a Treatment for Challenging Behavior for People With Intellectual and Developmental Disabilities: Support for the IASSIDD Policy Statement Opposing Its Use
43. Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck: An Illinois Cancer Center Study
44. Phase II study of amonafide in gastric adenocarcinoma: Illinois Cancer Center trial
45. Abstracts of papers and posters safe handling of medicines
46. Basic Trial Advocacy.
47. Bad history, bad policy, and bad law.
48. The truthsayer and the court: expert testimony on credibility.
49. Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E1912 Trial
50. Health care utilization and patient-related outcomes in patients with malignant bowel obstruction admitted to a United States safety net hospital.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.